AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

REPAGLINIDE

19 registrations across 2 African markets— 6 active

Markets with REPAGLINIDE

Recent registrations

Brand / ProductMarketHolderStatusExpires
GLINORM
Comprimé pelliculé / 1 mg
🇹🇳TunisiaSAIPHexpiredOct 2021
GLINORM
Comprimé pelliculé / 2 mg
🇹🇳TunisiaSAIPHexpiredOct 2021
GLINORM
Comprimé pelliculé / 1 mg
🇹🇳TunisiaSAIPHexpiredApr 2021
GLINORM
Comprimé pelliculé / 2 mg
🇹🇳TunisiaSAIPHexpiredApr 2021
REPAGLINID SANDOZ
Comprimé / 0.5 MG
🇹🇳TunisiaSANDOZ GmbHexpiredSept 2019
REPAGLINID SANDOZ
Comprimé / 1MG
🇹🇳TunisiaSANDOZ GmbHexpiredAug 2019
REPAGLINID SANDOZ
Comprimé / 2MG
🇹🇳TunisiaSANDOZ GmbHexpiredAug 2019
NOVONORM
Comprimé / 1 mg
🇹🇳TunisiaNOVO NORDISK A/S BagsvaerdexpiredSept 2013
NOVONORM
Comprimé / 2 mg
🇹🇳TunisiaNOVO NORDISK A/S BagsvaerdexpiredSept 2013
NOVONORM
Comprimé / 0.5 mg
🇹🇳TunisiaNOVO NORDISK A/S BagsvaerdexpiredSept 2013
NOVONORM
Comprimé / 2 MG
🇹🇳TunisiaNOVO NORDISK A/S BagsvaerdexpiredMar 2005
NOVONORM
Comprimé / 1 MG
🇹🇳TunisiaNOVO NORDISK A/S BagsvaerdexpiredOct 2002
NOVONORM
Comprimé / 0.5 MG
🇹🇳TunisiaNOVO NORDISK A/S BagsvaerdexpiredOct 2002
NOVONORM
COMPRIME
🇲🇦Moroccoactive
NOVONORM
COMPRIME
🇲🇦Moroccoactive
NOVONORM
COMPRIME
🇲🇦Moroccoactive
NOVONORM
COMPRIME
🇲🇦Moroccoactive
NOVONORM
COMPRIME
🇲🇦Moroccoactive
NOVONORM
COMPRIME
🇲🇦Moroccoactive

REPAGLINIDE in Africa — Regulatory Overview

REPAGLINIDE is registered across 2 African markets with 19 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 19 registrations, 6 (32%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.